TERMINATION OF RESEARCH COLLABORATION AGREEMENTS Sample Clauses

TERMINATION OF RESEARCH COLLABORATION AGREEMENTS. All Research Collaboration Agreements with TRACK-TBI will have a specified date upon which the research collaboration project will end. The end date may be extended through the amendment process, if both parties agree. The TRACK-TBI Leadership reserves the right to terminate a Research Collaboration Agreement or DUA/HTMA before the end date at the discretion of the Executive Committee with a 30-day written notice. Appendix 1: Research Collaboration Proposal Request Form Instructions: A completed and approved Research Collaboration Proposal Request is required to be submitted to the TRACK-TBI Executive Committee (care of xxxxx.xxxxxx@xxxx.xxx) and should be no more than 2 pages long. Authors are encouraged to contact the Biostatistics Core to receive assistance with the statistical analysis plan. Clinical site statisticians are also encouraged to participate in these consultations. Proposals will be reviewed by the TRACK-TBI Executive Committee. All aspects of manuscript development will be governed by this Guideline. Proposals should contain the following elements: Date: Investigator’s Name: Investigator’s Title: Organization or Clinical Center: E-mail: Telephone: TRACK-TBI Sponsor (if not a TRACK-TBI investigator): Other investigators who will be working on this analysis: Analysis Plan Title: TRACK-TBI Dataset files requested: Pilot Study ☐ TRACK-TBI U01 Study ☐ Biospecimen request ☐ Purpose of Data Request (check all that apply) TRACK-TBI Core (check all that apply) ☐ Exploratory ☐ Clinical Core ☐ Data analysis for manuscript ☐ Biospecimens Core ☐ Preliminary data for xxxxx proposal ☐ Neuroimaging Core ☐ Inputs for simulation model ☐ Biostatistics/CER Core ☐ Development of statistical methods ☐ Outcomes Core ☐ Other (describe) Please attach a 2-page description of your analysis plan including:
AutoNDA by SimpleDocs
TERMINATION OF RESEARCH COLLABORATION AGREEMENTS. 4 Appendix 1: Research Collaboration Proposal Form Appendix 2: TRACK-TBI Data Use Agreement/Human Materials Transfer Agreement Appendix 3: Publication and Authorship Guidelines Appendix 4: Biospecimen Sharing Policy TRACK-TBI Research Collaboration Policy
TERMINATION OF RESEARCH COLLABORATION AGREEMENTS. All Research Collaboration Agreements with TRACK-TBI will have a specified date upon which the research collaboration project will end. The end date may be extended through the amendment process, if both parties agree. The TRACK-TBI Leadership reserves the right to terminate a Research Collaboration Agreement or DUA/HTMA before the end date at the discretion of the Executive Committee with a 30-day written notice.

Related to TERMINATION OF RESEARCH COLLABORATION AGREEMENTS

  • Termination of Agreement If this Agreement is terminated by the Representatives in accordance with the provisions of Section 5 or Section 9(a)(i) hereof, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters.

  • Implementation of Agreement Each Party must promptly execute all documents and do all such acts and things as is necessary or desirable to implement and give full effect to the provisions of this Agreement.

  • Termination of Agreements (a) Except as set forth in Section 2.7(b), in furtherance of the releases and other provisions of Section 4.1, SpinCo and each member of the SpinCo Group, on the one hand, and Parent and each member of the Parent Group, on the other hand, hereby terminate any and all agreements, arrangements, commitments or understandings, whether or not in writing, between or among SpinCo and/or any member of the SpinCo Group, on the one hand, and Parent and/or any member of the Parent Group, on the other hand, effective as of the Effective Time. No such terminated agreement, arrangement, commitment or understanding (including any provision thereof which purports to survive termination) shall be of any further force or effect after the Effective Time. Each Party shall, at the reasonable request of the other Party, take, or cause to be taken, such other actions as may be necessary to effect the foregoing.

  • Grant Remedies Termination and Prohibited Activities 18 9.1 Remedies 18 9.2 Termination for Convenience 19 9.3 Termination for Cause 19

  • Termination by Licensee 10.1 Licensee will have the right at any time to terminate this Agreement in whole or as to any portion of Patent Rights by giving notice in writing to The Regents. Such Notice of Termination will be subject to Article 18. (Notices) and termination of this Agreement will be effective sixty (60) days after the effective date thereof.

  • Termination by Licensor Licensor, at its option, may immediately terminate the Agreement, or any part of Patent Rights, or any part of Field, or any part of Territory, or the exclusive nature of the license grant, upon delivery of written notice to Licensee of Licensor’s decision to terminate, if any of the following occur:

  • Period of Agreement This Agreement shall start on _, 20 (“Effective Date”), and end on , 20_ _, at 12:00 midnight (“Listing Period”), unless the expiration date is extended in writing.

  • Transition of Registry upon Termination of Agreement Upon expiration of the Term pursuant to Section 4.1 or Section 4.2 or any termination of this Agreement pursuant to Section 4.3 or Section 4.4, Registry Operator shall provide ICANN or any successor registry operator that may be designated by ICANN for the TLD in accordance with this Section 4.5 with all data (including the data escrowed in accordance with Section 2.3) regarding operations of the registry for the TLD necessary to maintain operations and registry functions that may be reasonably requested by ICANN or such successor registry operator. After consultation with Registry Operator, ICANN shall determine whether or not to transition operation of the TLD to a successor registry operator in its sole discretion and in conformance with the Registry Transition Process; provided, however, that (i) ICANN will take into consideration any intellectual property rights of Registry Operator (as communicated to ICANN by Registry Operator) in determining whether to transition operation of the TLD to a successor registry operator and (ii) if Registry Operator demonstrates to ICANN’s reasonable satisfaction that (A) all domain name registrations in the TLD are registered to, and maintained by, Registry Operator or its Affiliates for their exclusive use, (B) Registry Operator does not sell, distribute or transfer control or use of any registrations in the TLD to any third party that is not an Affiliate of Registry Operator, and (C) transitioning operation of the TLD is not necessary to protect the public interest, then ICANN may not transition operation of the TLD to a successor registry operator upon the expiration or termination of this Agreement without the consent of Registry Operator (which shall not be unreasonably withheld, conditioned or delayed). For the avoidance of doubt, the foregoing sentence shall not prohibit ICANN from delegating the TLD pursuant to a future application process for the delegation of top-­‐level domains, subject to any processes and objection procedures instituted by ICANN in connection with such application process intended to protect the rights of third parties. Registry Operator agrees that ICANN may make any changes it deems necessary to the IANA database for DNS and WHOIS records with respect to the TLD in the event of a transition of the TLD pursuant to this Section 4.5. In addition, ICANN or its designee shall retain and may enforce its rights under the Continued Operations Instrument for the maintenance and operation of the TLD, regardless of the reason for termination or expiration of this Agreement.

  • DURATION OF AGREEMENT All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement) by reason of Indemnitee’s Corporate Status, whether or not Indemnitee is acting in any such capacity at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!